Department of Internal Medicine Grand Rounds
Thursday, December 9, 2021
12:00pm - 1:00pm
Zoom Attendance Only
Hania Kassem, MD
Division of Nephrology, UTMB
“Delaying the Progression of Diabetic Kidney Disease: Beyond the ACE Inhibitors and ARB’s”
Objectives: At this conclusion of this presentation, participants should be able to:
- Review current standard practice in managing diabetic kidney disease (DKD)
- Analyze benefits of SGLT-2 inhibitors in CKD patients
- Examine the role of non-steriodal mineralocorticoid receptor antagonists in DKD
Target Audience and Needs: Internal Medicine faculty, staff, registered nurses, residents, fellows, students, and internists specializing in Allergy & Immunology,
Cardiology, Endocrinology, Gastroenterology, General Medicine, Geriatrics, Hematology & Oncology, Infectious Diseases, Nephrology, Palliative Care, Pulmonary Critical Care & Sleep Medicine, and Rheumatology need to be regularly updated with
new research and guidelines regarding the evaluation and management of medical disorders and implement them in clinical practice to enhance the quality of patient care and improve patient outcomes.
Educational Methods: Educational methods will include lectures, case presentations, literature review, and panel discussion.
Activity Evaluation: Participants may be asked to complete a session evaluation.
Accreditation/Credit Designation: Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Everyone is welcome.